Tag Archives: Anthony Vendetti

Maxim Group Remains a Buy on Hain Celestial (HAIN)

Maxim Group analyst Anthony Vendetti reiterated a Buy rating on Hain Celestial (HAIN – Research Report) yesterday and set a price target of $28. The company’s shares closed last Monday at $19.05. Vendetti observed: “Market open, HAIN reported mixed F4Q19

Milestone Scientific (MLSS) Receives a Buy from Maxim Group

In a report released yesterday, Anthony Vendetti from Maxim Group maintained a Buy rating on Milestone Scientific (MLSS – Research Report), with a price target of $1. The company’s shares closed last Monday at $0.56. Vendetti wrote: “2019, MLSS reported

Maxim Group Maintains Their Hold Rating on Restoration Robotics Inc (HAIR)

In a report released yesterday, Anthony Vendetti from Maxim Group maintained a Hold rating on Restoration Robotics Inc (HAIR – Research Report). The company’s shares closed last Monday at $0.68, close to its 52-week low of $0.35. Vendetti commented: “2019,

Maxim Group Keeps Their Hold Rating on Applied DNA Sciences (APDN)

Maxim Group analyst Anthony Vendetti maintained a Hold rating on Applied DNA Sciences (APDN – Research Report) yesterday. The company’s shares closed last Monday at $0.28, close to its 52-week low of $0.25. Vendetti observed: “Yesterday, after the Market close,

Maxim Group Remains a Hold on Viveve Medical Inc (VIVE)

Maxim Group analyst Anthony Vendetti reiterated a Hold rating on Viveve Medical Inc (VIVE – Research Report) yesterday. The company’s shares closed yesterday at $0.15, close to its 52-week low of $0.14. Vendetti said: “Yesterday, after the Market close, VIVE

Maxim Group Reiterates a Buy Rating on Joint Corp (JYNT)

Maxim Group analyst Anthony Vendetti reiterated a Buy rating on Joint Corp (JYNT – Research Report) yesterday and set a price target of $25. The company’s shares closed yesterday at $18.25. Vendetti wrote: “Market close, JYNT reported relatively inline 2Q19